Remove evergreening-of-patents
article thumbnail

Evergreening of Patents

Kashishipr

The evergreening of patents is a common element of pharmaceutical patents. The most crucial method that global medicine enterprises use is drug evergreening of patents. The evergreening of patents means securing wealth from high sales volume for a long time. Country Specific Takes on Evergreening.

Patent 105
article thumbnail

Draft Patent Amendment Rules: Big Impact but Limited Commentary 

SpicyIP

Image from here The Draft Patent (Amendment) Rules, 2023 is quite the mixed bag. The Indian patent prosecution stage holds a very important spot in the overall patent regime of the country. Union of India where the Delhi High Court observed the delay in patent prosecution owing to both the applicants as well as the opponents.)

Patent 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Special 301 Report 2023: Reflections from Public Health Perspective

SpicyIP

India, which has featured in this list multiple times in the past, (as highlighted on the blog by different authors over the years) finds its position in the list yet again, for remaining as “one of the world’s most challenging major economies with respect to protection and enforcement of IP”. 56, para 3).

Reporting 137
article thumbnail

Supermarket Showdown (Lidl v Tesco) – Lidl’s rights (trade marks and copyright) in the Lidl logo are infringed by Tesco’s “Clubcard Price” signs

Kluwer Copyright Blog

Trade mark infringement – Lidl’s trade mark for the Lidl logo was infringed by Tesco’s Clubcard Price(s) signs, which took unfair advantage of Lidl’s reputation for low prices and damaged the distinctive character of Lidl’s logo. The judge held that certain of these Wordless Marks were invalid for bad faith.

article thumbnail

USMCA: Implications for Biologics and Innovation

Bio Law Blog

The USMCA contains a number of key and last-minute revisions that implicate biologic medicines and patent obligations. The USMCA was also amended to remove the obligation to provide patents for new uses of a known product. In the United States, it has long been established that new uses of old drugs are patentable. patent law.